Last reviewed · How we verify
enoxaparin only
At a glance
| Generic name | enoxaparin only |
|---|---|
| Sponsor | Hallym University Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction (NA)
- A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants (PHASE2)
- A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants (PHASE1)
- A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA (PHASE2)
- Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery (NA)
- Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (PHASE2)
- Informative Video Before LMWH Postpartum - Randomized Controlled Trial (NA)
- Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |